NO993750D0 - Lipidkomplekser og liposomer fra svaert uopplöselige platinakomplekser - Google Patents

Lipidkomplekser og liposomer fra svaert uopplöselige platinakomplekser

Info

Publication number: NO993750D0
Authority: NO; Norway
Prior art keywords: complexes; liposomes; highly insoluble; lipid; insoluble platinum
Prior art date: 1997-02-05

Application number

NO993750A

Other languages

English (en)

Norwegian (no)

Other versions

NO993750L (no

Inventor

Mathew Cherian

Original Assignee

Upjohn Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-02-05

Filing date

1999-08-03

Publication date

1999-08-03

1999-08-03 Application filed by Upjohn Co filed Critical Upjohn Co

1999-08-03 Publication of NO993750L publication Critical patent/NO993750L/no

1999-08-03 Publication of NO993750D0 publication Critical patent/NO993750D0/no

Links

150000002632 lipids Chemical class 0.000 title abstract 2
239000002502 liposome Substances 0.000 title abstract 2
150000003057 platinum Chemical class 0.000 title 1
BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 abstract 2
239000000203 mixture Substances 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
150000003904 phospholipids Chemical class 0.000 abstract 1
229910052697 platinum Inorganic materials 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6905—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion
- A61K47/6911—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion the form being a liposome
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Dispersion Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

NO993750A 1997-02-05 1999-08-03 Lipidkomplekser og liposomer fra svaert uopplöselige platinakomplekser NO993750D0 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US3737797P	1997-02-05	1997-02-05
PCT/US1998/000035 WO1998033481A1 (fr)	1997-02-05	1998-01-28	Complexes de lipides et liposomes a base de complexes de platine fortement insolubles

Publications (2)

Publication Number	Publication Date
NO993750L NO993750L (no)	1999-08-03
NO993750D0 true NO993750D0 (no)	1999-08-03

Family

ID=21894020

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO993750A NO993750D0 (no)	1997-02-05	1999-08-03	Lipidkomplekser og liposomer fra svaert uopplöselige platinakomplekser

Country Status (22)

Country	Link
US (1)	US6287593B2 (fr)
EP (1)	EP0975329B1 (fr)
JP (1)	JP2002513396A (fr)
KR (1)	KR100578705B1 (fr)
CN (2)	CN1096263C (fr)
AT (1)	ATE284204T1 (fr)
AU (1)	AU749220B2 (fr)
BR (1)	BR9815445A (fr)
CA (1)	CA2279279C (fr)
DE (1)	DE69828038T2 (fr)
DK (1)	DK0975329T3 (fr)
EA (1)	EA002630B1 (fr)
ES (1)	ES2234094T3 (fr)
HK (2)	HK1029059A1 (fr)
HU (1)	HUP0001266A3 (fr)
IL (1)	IL131008A (fr)
NO (1)	NO993750D0 (fr)
NZ (1)	NZ337502A (fr)
PL (1)	PL192633B1 (fr)
PT (1)	PT975329E (fr)
UA (1)	UA71540C2 (fr)
WO (1)	WO1998033481A1 (fr)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL138723A (en)	1998-04-03	2005-11-20	Ajinomoto Kk	Composition containing cisplatin and stilbene for treatment of tumors
US6476068B1 (en)	2001-12-06	2002-11-05	Pharmacia Italia, S.P.A.	Platinum derivative pharmaceutical formulations
US9186322B2 (en) *	2002-08-02	2015-11-17	Insmed Incorporated	Platinum aggregates and process for producing the same
JP2006525368A (ja) *	2003-05-02	2006-11-09	アロネックス，ファーマシューティカルズ，インコーポレーテッド	脂質白金錯体およびその使用方法
CA2525973A1 (fr) *	2003-05-20	2004-12-09	Aronex Pharmaceuticals, Inc.	Chimiotherapie combinee comprenant capecitabine et un complexe a base de platine liposomique
AU2003239510A1 (en) *	2003-05-20	2005-01-21	Aronex Pharmaceuticals, Inc.	Combination chemotherapy comprising gemcitabine and a liposomal platinum complex
WO2004103382A1 (fr) *	2003-05-20	2004-12-02	Aronex Pharmaceuticals, Inc.	Chimiotherapie combinee comprenant 5-fluorouracil ou un de ses derives et un complexe de platine liposomal
JP2007504177A (ja) *	2003-09-02	2007-03-01	プリヴァ−ラケマ，エー．エス．	医薬組成物、その製造方法及び治療上の使用
EP1734937A1 (fr) *	2004-03-26	2006-12-27	Cell Therapeutics Europe S.R.L.	Preparations de nanoparticules de composes platine
WO2006084248A2 (fr) *	2005-02-04	2006-08-10	Antigenics, Inc.	Compositions contenant un complexe de platine, un lipide et un tensioactif
US9107824B2 (en)	2005-11-08	2015-08-18	Insmed Incorporated	Methods of treating cancer with high potency lipid-based platinum compound formulations administered intraperitoneally
US20070178147A1 (en) *	2005-12-08	2007-08-02	Desai Narendra R	Liposomal compositions
CZ300424B6 (cs) *	2006-06-20	2009-05-13	Pliva - Lachema A. S.	Farmaceutická kompozice pro perorální podání
RU2563997C2 (ru) *	2009-09-21	2015-09-27	Джей ДаблЮ ФАРМАСЬЮТИКАЛ КОРПОРЭЙШН	Наночастицы оксалиплатина и способ их получения
WO2012006101A2 (fr)	2010-06-28	2012-01-12	The General Hospital Corporation	Substituts sanguins et utilisations associées
CN102276674A (zh) *	2011-06-24	2011-12-14	天津大学	用于肿瘤靶向治疗的含半乳糖铂配合物及其制备方法
CN102286050A (zh) *	2011-06-24	2011-12-21	天津大学	用于肿瘤靶向治疗的含葡萄糖铂配合物及其制备方法
CN102286049A (zh) *	2011-06-24	2011-12-21	天津谷堆生物医药科技有限公司	用于肿瘤治疗的水溶性铂配合物及其制备方法
CN102716145A (zh) *	2012-06-20	2012-10-10	天津谷堆生物医药科技有限公司	含糖铂配合物在制备防治肿瘤药物的用途
US20150209281A1 (en)	2012-07-18	2015-07-30	Onyx Therapeutics, Inc.	Liposomal compositions of epoxyketone-based proteasome inhibitors
US11291644B2 (en)	2012-09-04	2022-04-05	Eleison Pharmaceuticals, Llc	Preventing pulmonary recurrence of cancer with lipid-complexed cisplatin
BR112015022415A2 (pt)	2013-03-13	2017-07-18	Mallinckrodt Llc	composições de cisplatina lipossômica para terapia contra câncer
CN104546722B (zh) *	2015-02-10	2017-05-24	中国医学科学院医药生物技术研究所	米铂脂质体和制法
CN110590855B (zh) *	2016-01-25	2023-05-12	沈阳药科大学	铂类配合物的制备方法及其含有该铂类配合物的脂质体与制备方法
JP2020500020A (ja)	2016-11-14	2020-01-09	ノバルティスアーゲー	融合誘導性タンパク質ｍｉｎｉｏｎに関連する組成物、方法、および治療上の使用
CN114652680A (zh) *	2020-12-24	2022-06-24	沈阳药科大学	制备脂质体的方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0113508A1 (fr) *	1982-11-04	1984-07-18	Inco Research & Development Center, Inc.	Composés de platine hydrophobiques et leur préparation
US5384127A (en) *	1985-10-18	1995-01-24	Board Of Regents, The University Of Texas System	Stable liposomal formulations of lipophilic platinum compounds
US4927571A (en) *	1987-05-18	1990-05-22	Liposome Technology, Inc.	Preparation of injectable doxorubicin/liposome suspension
CA1339034C (fr) *	1988-08-22	1997-04-01	Paul A. Tremblay	Complexes de platine d'isomeres uniques d'acides neoalkyliques
US5393909A (en) *	1988-11-22	1995-02-28	Board Of Regents, The University Of Texas System	Diamine platinum complexes as antitumor agents
JPH03200795A (ja) *	1989-12-28	1991-09-02	Nippon Kayaku Co Ltd	脂質親和性白金錯体及びそれを含有する製剤
US5843475A (en) *	1996-12-06	1998-12-01	Board Of Regents, The University Of Texas System	Delivery and activation through liposome incorporation of diaminocyclohexane platinum (II) complexes

1998
- 1998-01-28 ES ES98903358T patent/ES2234094T3/es not_active Expired - Lifetime
- 1998-01-28 KR KR1019997007031A patent/KR100578705B1/ko not_active IP Right Cessation
- 1998-01-28 EP EP98903358A patent/EP0975329B1/fr not_active Expired - Lifetime
- 1998-01-28 NZ NZ337502A patent/NZ337502A/en unknown
- 1998-01-28 AT AT98903358T patent/ATE284204T1/de not_active IP Right Cessation
- 1998-01-28 BR BR9815445-1A patent/BR9815445A/pt not_active Application Discontinuation
- 1998-01-28 CN CN98807276A patent/CN1096263C/zh not_active Expired - Fee Related
- 1998-01-28 DK DK98903358T patent/DK0975329T3/da active
- 1998-01-28 EA EA199900715A patent/EA002630B1/ru not_active IP Right Cessation
- 1998-01-28 UA UA99094920A patent/UA71540C2/uk unknown
- 1998-01-28 WO PCT/US1998/000035 patent/WO1998033481A1/fr not_active Application Discontinuation
- 1998-01-28 PL PL334940A patent/PL192633B1/pl not_active IP Right Cessation
- 1998-01-28 PT PT98903358T patent/PT975329E/pt unknown
- 1998-01-28 CA CA002279279A patent/CA2279279C/fr not_active Expired - Fee Related
- 1998-01-28 DE DE69828038T patent/DE69828038T2/de not_active Expired - Fee Related
- 1998-01-28 CN CNB021504555A patent/CN1191067C/zh not_active Expired - Fee Related
- 1998-01-28 AU AU60154/98A patent/AU749220B2/en not_active Ceased
- 1998-01-28 JP JP53288498A patent/JP2002513396A/ja not_active Ceased
- 1998-01-28 HU HU0001266A patent/HUP0001266A3/hu unknown
- 1998-01-28 US US09/341,988 patent/US6287593B2/en not_active Expired - Fee Related
- 1998-01-28 IL IL13100898A patent/IL131008A/xx not_active IP Right Cessation
1999
- 1999-08-03 NO NO993750A patent/NO993750D0/no unknown
2000
- 2000-12-28 HK HK00108452A patent/HK1029059A1/xx not_active IP Right Cessation
2003
- 2003-09-11 HK HK03106511.4A patent/HK1054201B/zh not_active IP Right Cessation

Also Published As

Publication number	Publication date
IL131008A (en)	2003-06-24
HK1054201A1 (en)	2003-11-21
DE69828038D1 (de)	2005-01-13
BR9815445A (pt)	2001-09-25
EP0975329A1 (fr)	2000-02-02
CA2279279C (fr)	2008-10-14
ATE284204T1 (de)	2004-12-15
NO993750L (no)	1999-08-03
UA71540C2 (uk)	2004-12-15
DE69828038T2 (de)	2005-11-03
CN1096263C (zh)	2002-12-18
ES2234094T3 (es)	2005-06-16
US6287593B2 (en)	2001-09-11
IL131008A0 (en)	2001-01-28
DK0975329T3 (da)	2005-03-14
EA199900715A1 (ru)	2000-04-24
WO1998033481A1 (fr)	1998-08-06
EP0975329B1 (fr)	2004-12-08
US20010010822A1 (en)	2001-08-02
HUP0001266A2 (hu)	2000-11-28
PT975329E (pt)	2005-03-31
PL334940A1 (en)	2000-03-27
CN1422619A (zh)	2003-06-11
AU749220B2 (en)	2002-06-20
HUP0001266A3 (en)	2001-02-28
EA002630B1 (ru)	2002-08-29
JP2002513396A (ja)	2002-05-08
CN1191067C (zh)	2005-03-02
PL192633B1 (pl)	2006-11-30
HK1054201B (zh)	2005-09-09
CN1264295A (zh)	2000-08-23
NZ337502A (en)	2001-02-23
CA2279279A1 (fr)	1998-08-06
AU6015498A (en)	1998-08-25
HK1029059A1 (en)	2001-03-23
KR100578705B1 (ko)	2006-05-12
KR20000070771A (ko)	2000-11-25

Publication	Publication Date	Title
NO993750D0 (no)	1999-08-03	Lipidkomplekser og liposomer fra svaert uopplöselige platinakomplekser
ATE207738T1 (de)	2001-11-15	Verfahren zur baladung von lipidvesikeln
DE69620877T2 (de)	2002-12-12	Arzneimittelformulierungen für il-12
DE69528057T2 (de)	2003-11-06	Tocopherolzusammensetzungen zur Abgabe von biologisch aktiven Substanzen
DK0758248T3 (da)	2003-10-27	Formuleringer til faktor IX
HUP0004396A2 (hu)	2001-06-28	A lipoprotein-oxidáció gátlására szolgáló, hatóanyagként hidroxilezett koleszterincsökkentő szert tartalmazó gyógyszerkészítmények
AU3559895A (en)	1996-04-26	Polyethylene glycol modified ceramide lipids and liposome uses thereof
ATE554750T1 (de)	2012-05-15	Hydrophobe pharmazeutische wirkstoffe enthaltende zubereitungen
HUP9801370A3 (en)	2000-10-30	Stable protein:phospholipid compositions and methods for production thereof
ES8800037A1 (es)	1987-10-16	Procedimiento para solubilizar drogas en propulsores de aerosol a base de clorofluorcarburos
ATE195721T1 (de)	2000-09-15	Lipopolyamine als transfectionsmittel und ihre pharmazeutischen anwendungen
TR200001977T2 (tr)	2000-12-21	Lipofilik glukokortikosteroit içeren miseller ihtiva eden bileşimler
MY111841A (en)	2001-01-31	Injectable liposomal pharmaceutical preparations
TR199801861T2 (xx)	1998-12-21	Farmas�tik olarak yararl� bile�imler.
CA2326348A1 (fr)	1999-10-07	Compositions de liposomes de bupivacaine et leurs methodes de preparation
FR2763592B1 (fr)	1999-07-16	Nouveaux derives glycosyles des ginkgolides, leur application en tant que medicaments et compositions pharmaceutiques les contenant
HUP0002236A2 (hu)	2003-08-28	Oldhatóvá tett szertralinkészítmények és eljárás az előállításukra
FR2735361B1 (fr)	1997-07-11	Compositions contenant des vesicules lipidiques renfermant des nanopigments